{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:04:28Z","timestamp":1794218668399,"version":"4.8.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Cirrhotic patients are at a high risk of developing radiation-induced liver toxicities despite the modern safe radiation delivery techniques due to the low liver tolerance. Recent studies demonstrated a potential risk of second primary malignancies (SPMs) following radiotherapy (RT) with further investigations for strategies to decrease RT-induced SPMs. However, it is insufficiently addressed if developing liver SPMs is a serious adverse event following RT for cirrhotic patients. Thus, we aimed to quantitatively assess the risk of gastrointestinal (GI) and liver SPMs following RT in patients with liver fibrosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The SEER*Stat beta software version 9.0.32 was used to obtain and analyze the data of patients with chronic liver disease diagnosed from 2010 to 2021. We sub-grouped patients according to the history of receiving RT for prior cancer treatment into two groups and excluded patients with unknown RT administration history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We observed 215 cirrhotic patients developed GI SPMs (O\/E\u00a0=\u00a02.76, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05, ER\u00a0=\u00a045.51), 106 of them developed liver SPMs (O\/E\u00a0=\u00a08.80, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Patients with liver cirrhosis who received RT had an increased risk for GI SPMs (Observed\u00a0=\u00a024, O\/E\u00a0=\u00a03.34, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) compared to who received no RT (O\/E\u00a0=\u00a02.71, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05, ER\u00a0=\u00a043.72). Liver SPMs after RT in cirrhotic patients had an O\/E of 12.31 (Observed\u00a0=\u00a013, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) while the group who received no RT had an O\/E of 8.46 (Observed\u00a0=\u00a093, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05, ER\u00a0=\u00a029.77).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Cirrhotic patients who received RT before had an increased risk for GI SPMs by three folds and a 12-fold increased risk for liver SPMs. However, who received no RT had an 8-fold increased risk for liver SPM. Thus, screening for HCC in cirrhotic patients exposed to RT is a must for early detection and better management outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003446","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:00:36Z","timestamp":1748502036000},"page":"4742-4750","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Chronic liver disease and radiation-induced second primary liver malignancy: a retrospective cohort based on SEER database 2010\u20132021"],"prefix":"10.1097","volume":"87","author":[{"given":"Asmaa","family":"Ellaithy","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Serageldeen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhareth","family":"Alhusban","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Emad","family":"Seif","sequence":"additional","affiliation":[{"name":"Portsaid University, faculty of medicine, PortSaid, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Essam","family":"Abdelhamid","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3972-4950","authenticated-orcid":false,"given":"Bushra","family":"Al-Shaikh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Sana\u2019a University, Sana\u2019a, Yemen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Sayed","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam Mohamed","family":"Elshennawy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Kafr Alsheikh University, Kafr Alshaikh, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ellaithy","sequence":"additional","affiliation":[{"name":"High committee of health specialities, Ministry of Health and population, Egypt"},{"name":"Faculty of Medicine, Cairo University Kasr Alainy, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"638","DOI":"10.21037\/atm-20-2059","article-title":"Second primary malignancies among cancer patients","volume":"8","author":"Zheng","year":"2020","journal-title":"Ann Transl Med"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1470-2045(06)70759-8","article-title":"Role of radiotherapy in cancer control in low-income and middle-income countries","volume":"7","author":"Barton","year":"2006","journal-title":"Lancet Oncol"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.2014.55.1143","article-title":"Role of radiation therapy in palliative care of the patient with cancer","volume":"32","author":"Lutz","year":"2014","journal-title":"J Clin Oncol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.21037\/atm-20-200","article-title":"Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies","volume":"10","author":"Yang","year":"2022","journal-title":"Ann Transl Med"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jnci.2015.08.001","article-title":"Radiation induced liver disease: a clinical update","volume":"28","author":"Benson","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semradonc.2018.06.007","article-title":"Radiation-induced liver disease and modern radiotherapy","volume":"28","author":"Koay","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.04.035","article-title":"Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20250806","first-page":"297","article-title":"Hepatic cirrhosis","volume":"13","author":"Fortea","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ijrobp.2009.09.063","article-title":"Inactivation of Kupffer cells by gadolinium chloride protects murine liver from radiation-induced apoptosis","volume":"76","author":"Du","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3350\/cmh.2024.0351","article-title":"Prevalence of clinically significant liver fibrosis in the general population: a systematic review and meta-analysis","volume":"30","author":"Kim","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2011.05.003","article-title":"Hepatic radiation toxicity: avoidance and amelioration","volume":"21","author":"Guha","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1634\/theoncologist.2019-0266","article-title":"Second primary malignancies in patients with colorectal cancer: a population-based analysis","volume":"25","author":"Jia","year":"2020","journal-title":"Oncologist"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"713637","DOI":"10.3389\/fonc.2021.713637","article-title":"Second primary malignancies in patients with hepatocellular carcinoma: a population-based analysis","volume":"11","author":"Kong","year":"2021","journal-title":"Front Oncol"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2407-13-394","article-title":"Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Cancer"},{"key":"R16-20250806","first-page":"9","article-title":"Risk of second primary cancers among long-term survivors of breast cancer","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15441\/ceem.17.261","article-title":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department","volume":"5","author":"Lee","year":"2018","journal-title":"Clin Exp Emerg Med"},{"key":"R23-20250806","first-page":"1","article-title":"Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"R24-20250806","first-page":"1","article-title":"Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study","volume":"21","author":"Zhou","year":"2023","journal-title":"J Transl Med"},{"key":"R25-20250806","article-title":"Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis","volume":"28","author":"Tang","year":"2023","journal-title":"Tech Coloproctol"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","article-title":"Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients","volume":"121","author":"Grantzau","year":"2016","journal-title":"Radiother Oncol"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000356115","article-title":"Radiation-induced secondary malignancy in prostate cancer: a systematic review and meta-analysis","volume":"93","author":"Jin","year":"2014","journal-title":"Urol Int"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"De Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"R29-20250806","first-page":"13","article-title":"Radiation induced liver damage in patients with liver cancer","volume":"87","author":"Nassar","year":"2019","journal-title":"Cairo Univ"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00261-014-0125-x","article-title":"Radiation-induced liver disease as a mimic of liver metastases at serial PET\/CT during neoadjuvant chemoradiation of distal esophageal cancer","volume":"39","author":"Grant","year":"2014","journal-title":"Abdom Imaging"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:15:48Z","timestamp":1754496948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003446","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"2025-04-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}